SCHEMBL2375581

SCHEMBL2375581

O=C1CC(c2ccccc2)=NN1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 1.00
SMN1; SMN2 Q16637 4/20 0.69
ALDH1A1 P00352 6/20 0.50
PDE3B Q13370 3/20 0.44
PDE3A Q14432 3/20 0.44
RAB9A P51151 4/20 0.43
GPR119 Q8TDV5 1/20 0.41
NPC1 O15118 3/20 0.40
CFTR P13569 1/20 0.40
GOPC Q9HD26 1/20 0.40
HTT P42858 1/20 0.40
LMNA P02545 1/20 0.40
PDE2A O00408 1/20 0.39
MAPT P10636 2/20 0.39
KCNH2 Q12809 1/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
CHEK1 O14757 1/20 0.39
AURKA O14965 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11846026 0.96 AXL (0.92) AXLSMN1; SMN2ALDH1A1PDE3BPDE3A
SCHEMBL27995075 0.87 AXL (0.77) AXLSMN1; SMN2ALDH1A1PDE3BPDE3A
SCHEMBL5566954 0.82 AXL (0.69) AXLSMN1; SMN2ALDH1A1PDE3BPDE3A
SCHEMBL2798028 0.82 SMN1; SMN2 (1.00) AXLSMN1; SMN2PDE3BPDE3AGPR119
SCHEMBL13335345 0.80 AXL (0.67) AXLSMN1; SMN2ALDH1A1PDE3BPDE3A
SCHEMBL5561143 0.80 AXL (0.67) AXLSMN1; SMN2ALDH1A1PDE3BPDE3A
SCHEMBL5561070 0.80 AXL (0.67) AXLSMN1; SMN2ALDH1A1PDE3BPDE3A
SCHEMBL20279531 0.80 AXL (0.67) AXLSMN1; SMN2ALDH1A1PDE3BPDE3A
SCHEMBL5566548 0.80 AXL (0.66) AXLSMN1; SMN2ALDH1A1PDE3BPDE3A
SCHEMBL12402426 0.80 AXL (0.66) AXLSMN1; SMN2ALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 888 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036739-A 3,4' -Pyrano [2,3-c ] pyrazole spiro oxindole derivative, and preparation method and application thereof 遵义医药高等专科学校 2026-05-15 CN claimed
CN-122036691-A 3-Phenyl-1H-pyrazol-5-alcohol spliced indole derivatives, and preparation method and application thereof 遵义医药高等专科学校 2026-05-15 CN claimed
CN-118056816-A Pyrazole-3-ketone derivative, and preparation method and application thereof 沈阳药科大学 2024-05-21 CN claimed
US-6867192-B1 Compounds useful in the treatment of inflammatory diseases GLAXO GROUP LIMITED (GB) 2005-03-15 US claimed
EP-1140837-B1 COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES GLAXO GROUP LTD (GB) 2004-08-18 EP claimed
CN-1330637-A Compounds useful in treatment of infammatory diseases GLAXO GROUP LTD (GB) 2002-01-09 CN claimed
EP-1140837-A1 COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2001-10-10 EP claimed
WO-2000037444-A1 COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2000-06-29 WO claimed
EP-0007019-A1 5-Phenyl-pyrazole derivatives and their salts, processes for their preparation and medicines containing them Kali-Chemie Pharma GmbH (DE) 1980-01-23 EP claimed
US-6423486-B1 None US disclosed
CN-122036691-A 3-Phenyl-1H-pyrazol-5-alcohol spliced indole derivatives, and preparation method and application thereof 遵义医药高等专科学校 2026-05-15 CN disclosed
CN-122036739-A 3,4' -Pyrano [2,3-c ] pyrazole spiro oxindole derivative, and preparation method and application thereof 遵义医药高等专科学校 2026-05-15 CN disclosed
US-20260042902-A1 RUBBER COMPOSITION AND POWER STEERING HOSE YOKOHAMA RUBBER CO LTD (JP) 2026-02-12 US disclosed
US-20240208964-A1 PYRIDOPYRIMIDINES AND METHODS OF THEIR USE YUMANITY THERAPEUTICS, INC. 2024-06-27 US disclosed
US-4923792-A BENZYLIDENE LEUCO COMPOUNDS AS COLOR-GENERATING REDUCING AGENTS, TOPCOAT OF POLYVINYL ALCOHOL MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1990-05-08 US disclosed
US-4883747-A LIGHT SENSITIVE SILVER HALIDE, ORGANIC ACID SILVER SALT, LEUCO DYE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-11-28 US disclosed
EP-0294099-A2 Colour photothermographic elements MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1988-12-07 EP disclosed
EP-0174131-A2 Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them FISONS plc (GB) 1986-03-12 EP disclosed
EP-0007019-A1 5-Phenyl-pyrazole derivatives and their salts, processes for their preparation and medicines containing them Kali-Chemie Pharma GmbH (DE) 1980-01-23 EP disclosed
EP-0007019-A1 5-Phenyl-pyrazole derivatives and their salts, processes for their preparation and medicines containing them Kali-Chemie Pharma GmbH (DE) 1980-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208964-A1 PYRIDOPYRIMIDINES AND METHODS OF THEIR USE PNPO, DPYD, PYGB AXL 4694/4885SMN1; SMN2 7/4885ALDH1A1 945/4885
US-20260042902-A1 RUBBER COMPOSITION AND POWER STEERING HOSE HSPA4L, ROS1, HSPE1 AXL 2221/4885SMN1; SMN2 1149/4885ALDH1A1 1195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.